How do I subscribe to ongoing alerts?

Subscribe to /feed/disease/gestational-trophoblastic-neoplasia.xml in Feedly / Inoreader. Every regulatory action, PDUFA date, or trial completion in this treatment area lands in your feed automatically.

Last reviewed 2026-06-10 · How we verify

Gestational trophoblastic neoplasia — Treatment Landscape & Competitive Intelligence

Name: Drug Landscape Pharmaceutical Database
Creator: Drug Landscape
Published: 2026-01-01
License: https://creativecommons.org/licenses/by/4.0/

Gestational trophoblastic neoplasia (disease) competitive landscape: 4 marketed treatments tracked, 0 Phase 3 candidates, 0 Phase 2 candidates. Recent regulatory actions and upcoming PDUFA dates across the entire treatment set.

4 marketed 0 Phase 3 0 Phase 2 Live · 30-min refresh

Marketed treatment landscape

Approved drugs treating Gestational trophoblastic neoplasia, deduplicated by molecule. See the full disease page for line-of-therapy detail.

Drug	Generic	Sponsor	Class	Target	First approval
Cosmegen	DACTINOMYCIN	Recordati	Actinomycin [EPC]	DNA	1964-01-01
Trexall	methotrexate	Generic (originally Lederle Laboratories)	Antifolate, DMARD	Canalicular multispecific organic anion transporter 1, High mobility group protein B1, Multidrug resistance-associated protein 4	1953-12-07
Vinblastin	Vinblastin	The Lymphoma Academic Research Organisation		Canalicular multispecific organic anion transporter 1, Multidrug resistance-associated protein 7, Multidrug resistance protein 1
Methotrexat	Methotrexat	Biocad		Canalicular multispecific organic anion transporter 1, High mobility group protein B1, Multidrug resistance-associated protein 4

Phase 3 pipeline

No Phase 3 pipeline candidates tracked.

Phase 2 pipeline

No Phase 2 pipeline candidates tracked.

Recent regulatory actions (last 90 days)

No regulatory actions in the last 90 days for this treatment set.

Upcoming PDUFA dates (next 180 days)

No PDUFA dates in the next 180 days for this treatment set.

Sponsor landscape

Biocad · 1 drug in Gestational trophoblastic neoplasia
Generic (originally Lederle Laboratories) · 1 drug in Gestational trophoblastic neoplasia
Recordati · 1 drug in Gestational trophoblastic neoplasia
The Lymphoma Academic Research Organisation · 1 drug in Gestational trophoblastic neoplasia

Subscribe to ongoing alerts

Every new regulatory action, PDUFA date, or trial completion in Gestational trophoblastic neoplasia:

Cite this brief

Drug Landscape (2026). Gestational trophoblastic neoplasia — Treatment Landscape & Competitive Intelligence Brief. https://druglandscape.com/ci/disease/gestational-trophoblastic-neoplasia. Accessed 2026-06-10.

Gestational trophoblastic neoplasia full disease profile — treatment pathway, diagnostics, guidelines
Browse all CI briefs
Build a custom feed

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing